24 November 2017
News and Views
Links and Services
A study in the latest issue of the Journal of Hepatology models the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.
Chronic hepatitis B is a common disease associated with high morbidity, mortality and impact on h
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors